日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score

针对接受免疫治疗的不可切除肝细胞癌患者,开发一种新的1年生存预后评分:ALIVE-IO评分

Pantzios, Spyridon; Sidiropoulos, Orestis; Syriha, Antonia; Ptohis, Nikolaos; Skouras, Ioannis; Mainta, Evgenia; Korkolis, Dimitris P; Machairas, Nikolaos; Sotiropoulos, Georgios C; Elefsiniotis, Ioannis

HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis D

HERACLIS_BLV_D:布洛韦肽治疗慢性丁型肝炎2年真实世界研究显示,治疗反应率不断提高

Papatheodoridi, Margarita; Sevastianos, Vasilios; Zachou, Kalliopi; Christodoulou, Dimitrios; Koskinas, John; Deutsch, Melanie; Alexopoulou, Alexandra; Elefsiniotis, Ioannis; Triantos, Christos; Gigi, Elena; Androutsakos, Theodoros; Karagiannakis, Dimitrios; Mani, Iliana; Dimitroulopoulos, Dimitrios; Mela, Maria; Sinakos, Emmanouil; Michopoulos, Spyros; Mimidis, Konstantinos; Papadopoulos, Nikolaos; Kontos, Athanasios; Veretanos, Christos; Lymperopoulos, Dimitrios; Giannoulis, George; Papadimitropoulos, Vasilios; Avramopoulou, Evdoxia; Papatheodoridi, Alkistis; Pantzios, Spyridon; Vasilieva, Larisa; Kranidioti, Hariklia; Koullias, Emmanouil; Psychos, Nikolaos; Fytili, Paraskevi; Vlachogiannakos, John; Cholongitas, Evangelos; Manolakopoulos, Spilios; Goulis, Ioannis; Dalekos, George; Papatheodoridis, George

Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment

个性化免疫:基于新抗原的疫苗正在革新肝细胞癌的治疗

Aggeletopoulou, Ioanna; Pantzios, Spyridon; Triantos, Christos

MicroRNA Landscape in Hepatocellular Carcinoma: Metabolic Re-Wiring, Predictive and Diagnostic Biomarkers, and Emerging Therapeutic Targets

肝细胞癌中的microRNA图谱:代谢重编程、预测和诊断生物标志物以及新兴治疗靶点

Liapopoulos, Dimitris; Sarantis, Panagiotis; Biniari, Theodora; Bousou, Thaleia-Eleftheria; Trifylli, Eleni-Myrto; Anastasiou, Ioanna A; Kokkali, Stefania; Korakaki, Dimitra; Pantzios, Spyridon; Koustas, Evangelos; Elefsiniotis, Ioannis; Karamouzis, Michalis V

Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL study

肝细胞癌的治疗模式和结果:来自希腊回顾性OPAL研究的真实世界经验

Koskinas, John; Pantzios, Spyridon; Deutsch, Melanie; Koullias, Emmanuel; Alexopoulou, Alexandra; Kranidioti, Hariklia; Michailidou, Elisavet; Goulis, Ioannis; Papagiouvanni, Ioanna; Koutroubakis, Ioannis; Samonakis, Dimitrios; Drygiannakis, Ioannis; Magafouraki, Eleni; Tsaliki, Evdokia; Manolakopoulos, Spilios; Elefsiniotis, Ioannis; Papatheodoridis, Georgios

Impact of neutrophil-to-lymphocyte ratio on survival outcomes among cirrhotic and non-cirrhotic patients with advanced hepatocellular carcinoma under atezolizumab-bevacizumab combination therapy

中性粒细胞与淋巴细胞比值对接受阿特珠单抗-贝伐珠单抗联合治疗的晚期肝细胞癌肝硬化和非肝硬化患者生存结局的影响

Pantzios, Spyridon; Sidiropoulos, Orestis; Syriha, Antonia; Stathopoulou, Ioanna; Rellou, Sofia; Nychas, Emmanouil; Barla, Georgia; Ptohis, Nikolaos; Elefsiniotis, Ioannis

Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels

血清维生素K缺乏诱导蛋白(PIVKA-II)、血清甲胎蛋白及其联合检测对诊断白种人肝硬化患者肝细胞癌的准确性,无论其血清甲胎蛋白水平是否具有诊断意义

Syriha, Antonia; Pantzios, Spyridon; Mandilara, Dionysia; Galanis, Petros; Stathopoulou, Ioanna; Barla, Georgia; Elefsiniotis, Ioannis

Efficacy of atezolizumab-bevacizumab combination therapy early after recurrence of hepatocellular carcinoma following resection or ablation with a curative intent

阿特珠单抗-贝伐珠单抗联合疗法在以根治为目的的肝细胞癌切除或消融术后复发早期疗效评估

Pantzios, Spyridon; Syriha, Antonia; Stathopoulou, Ioanna; Sidiropoulos, Orestis; Rellou, Sofia; Barla, Georgia; Ptohis, Nikolaos; Korkolis, Dimitris P; Sotiropoulos, Georgios C; Elefsiniotis, Ioannis

Efficacy of Αtezolizumab-Βevacizumab in BCLC-C cirrhotic patients with hepatocellular carcinoma according to the type of disease progression, the type of BCLC-C and liver disease severity

根据疾病进展类型、BCLC C分期和肝病严重程度评估阿特珠单抗联合贝伐珠单抗治疗BCLC-C期肝硬化合并肝细胞癌患者的疗效

Spyridon, Pantzios; Antonia, Syriha; Dionysia, Mandilara; Ioanna, Stathopoulou; Georgia, Barla; Nikolaos, Ptohis; Petros, Galanis; Ioannis, Elefsiniotis